Enlitic Inc · ASX:ENL
Enlitic — Shareholder Meeting (June 2025)
30 slides from Enlitic's shareholder meeting presentation, Jun 5, 2025
Slide 1: AGM Presentation and Addresses ASX Announcement
ASX Announcement 5 June 2025 Annual General Meeting – Presentation and Addresses Enlitic, Inc. (ASX: ENL) (“the Company”) attaches a copy of the Chair address and presentation to be made at today’s Annual General Meeting of the Company. – ENDS – For personal use only This announcement was authorised
Slide 2: Chairman's Address
Chairman’s Address At Enlitic, we are seeking to address a significant issue in the healthcare industry: the growing data volumes which are unstandardized, fragmented and under-utilised. This issue significantly compromises data quality and also impacts healthcare organisations’ ability to deliver c
Slide 3: Enlitic AGM 5 June 2025
For personal use only ENLITIC, INC. AI DRIVEN DATA MANAGEMENT FOR THE MEDICAL IMAGING SECTOR Annual General Meeting 5 June 2025
Slide 4: Important Notice and Disclaimer
Important Notice and Disclaimer This presentation has been prepared by Enlitic, Inc. (Enlitic or the Company) to provide summary information about the Company and its associated entities as at the date of this presentation, and the information in this presentation remains subject to change without n
Slide 5: Agenda
Agenda For personal use only Welcome & Chairman’s Address Formal Items of Business - Resolutions & Questions Closure of Annual General Meeting CEO’s Presentation - 2024 Highlights - Recent Strategic Progress - Growth Pathway & Outlook - Q&A 3
Slide 6: Chairman's Address
For personal use only Chairman’s Address Lawrence Gozlan, Chairman 4
Slide 7: Board And Executive Management
Board And Executive Management For personal use only Board of Directors Executive Management Lawrence B. Gozlan Michael Sistenich Board Chair, Non-Executive Director Executive Director & Chief Executive Officer Mr. Gozlan is the Chief Investment Officer and Founder of Michael has over 24 years of ex
Slide 8: Our Mission
Our Mission Enlitic’s mission is to revolutionise healthcare by leveraging AI and data, empowering evidence-based decision-making, enhancing research, and transforming healthcare delivery. For personal use only Industry Problems Solution Radiology departments are experiencing workflow and The Enliti
Slide 9: Transforming Care with Data
Transforming Care with Data Healthcare Providers and Technology Complex For personal use only Data Migration Innovation Empowering & Growth Value Creation Productivity Improvement 7
Slide 10: Meeting Procedures
Meeting Procedures For personal use only Questions Voting Proxies Resolutions 8
Slide 11: Resolution 1: Re-election of Michael Sistenich
Resolution 1 For personal use only Summary of Proxies Voted Re-election of Class II Director – Resolution 1 Michael Sistenich For 170,024,381 To consider, if thought fit, to pass the Open 600 following resolution as an ordinary resolution Against 0 by the affirmative vote of a majority of the votes
Slide 12: Resolution 2: Re-election of Sergio Duchini
Resolution 2 For personal use only Summary of Proxies Voted Re-election of Class II Director – Resolution 2 Sergio Duchini For 170,024,381 To consider, if thought fit, to pass the Open 600 following resolution as an ordinary resolution Against 0 by the affirmative vote of a majority of the votes cas
Slide 13: Resolution 3: Ratification of accounting firm
Resolution 3 For personal use only Summary of Proxies Voted Ratification of the Company’s accounting Resolution 3 firm For 170,024,381 To consider, if thought fit, to pass the following Open 600 resolution as an ordinary resolution by the Against 1 affirmative vote of a majority of the votes cast: A
Slide 14: Resolution 4: Ratification of Tranche 1 Placement
Resolution 4 For personal use only Summary of Proxies Voted Ratification of Common Stock (and Resolution 4 corresponding CDIs) under Tranche 1 of the For 123,404,501 Placement Open 600 To consider, if thought fit, to pass the following resolution as an ordinary resolution by the affirmative vote of
Slide 15: Resolution 5: Tranche 2 Placement issue
Resolution 5 For personal use only Summary of Proxies Voted Proposed issue of Common Stock (and Resolution 5 corresponding CDIs) under Tranche 2 of the For 123,404,501 Placement Open 600 To consider, if thought fit, to pass the following resolution as an ordinary resolution by the affirmative vote o
Slide 16: Resolution 6: Issue to Michael Sistenich
Resolution 6 For personal use only Summary of Proxies Voted Proposed issue of Common Stock (and Resolution 6 corresponding CDIs) to Mr Michael For 167,924,382 Sistenich (and/or his nominee(s)) under Tranche 2 of the Placement Open 600 To consider, if thought fit, to pass the following resolution as
Slide 17: Resolution 7: Issue of New Options
Resolution 7 For personal use only Summary of Proxies Voted Proposed issue of New Options Resolution 7 To consider, if thought fit, to pass the following For 121,302,091 resolution as an ordinary resolution by the affirmative Open 600 vote of a majority of the votes cast: Against 2,102,410 “That, fo
Slide 18: Resolution 8: New Options to Michael Sistenich
Resolution 8 For personal use only Summary of Proxies Voted Proposed issue of New Options to Mr Resolution 8 Michael Sistenich (and/or his nominee(s)) For 167,921,971 To consider, if thought fit, to pass the following Open 600 resolution as an ordinary resolution by the affirmative vote of a majorit
Slide 19: Resolution 9: Additional 10% Placement Capacity
Resolution 9 For personal use only Summary of Proxies Voted Approval of Additional 10% Placement Resolution 9 Capacity For 168,271,971 To consider, if thought fit, to pass the following Open 600 resolution as a special resolution by the affirmative vote of at least 75% of the votes cast: Against 1,7
Slide 20: CEO Presentation
For personal use only CEO Presentation Michael Sistenich, CEO 18
Slide 21: What we do
What we do For personal use only Enlitic is a software Enlitic’s 2024 Enlitic is at the The progress Enlitic development acquisition of Laitek, forefront of is making is company that uses one of the major empowering reflected in the artificial intelligence providers of tech- healthcare pipeline grow
Slide 22: 2024 Highlights
2024 Highlights For personal use only Release of Strategic Ensight 2.0 acquisition of ahead of schedule Laitek, Inc. 129% increase in revenue Pipeline strengthened by acquisition of Laitek, up 40.5% on 2023 GE HealthCare 16 new agreements signed MSA Signed with Laitek US$1.0m in savings through cost
Slide 23: Opportunity through technology: Ensight 2.0
Opportunity through technology Ensight 2.0 For personal use only Referring Clinics Referring Hospitals Target PACS Standardised, DICOM de-identified, Medical anonymised Primary imaging DICOM Hospital studies Data Migration Medical imaging Target Systems studies Internal Storage Cost M&A Upgrades to
Slide 24: Laitek: Solving Complex Problems Efficiently
Laitek: Solving Complex Problems Efficiently An essential component of the medical imaging ecosystem For personal use only TECH ENABLED DATA MIGRATION THE PREMISE IS SIMPLE THE REALITY: HIGHLY COMPLEX Many millions of studies encompassing petabytes of data are needed to be moved The process of extra
Slide 25: Recent Business Highlights
Recent Business Highlights Significant Commercial Progress For personal use only • Migration pipeline1 grown by more than US$60m since Laitek acquisition. • Secured US$1.6m (A$2.6m) of new contract revenue to 23rd April 25, with 75% expected to be recognized in CY25. • Additional US$0.6k (A$0.9m) of
Slide 26: GE HealthCare Relationship Formalized
GE HealthCare Relationship Formalized GEHC Genesis Portfolio For personal use only GEHC announced a new cloud-suite of enterprise imaging solutions at HIMSS 2025. Genesis Cloud Enterprise Imaging SaaS Solutions • Designed to improve patient care coordination, reduce operational costs and maintain ro
Slide 27: Enlitic Combined Pipeline
Enlitic Combined Pipeline1 Accelerating Revenue Targets via Advancing Key Pipeline Opportunities For personal use only Total Pipeline Pipeline Stage No. of Contracts Contract Value Pipeline remains healthy and growing Pending Progression2 37 $32.0m • Focus on conversion and implementation. ENSIGHT •
Slide 28: Our Pathway to Growth
Our Pathway to Growth For personal use only Material interest in Initial focus to lead with combined Ensight and Migration services as Migration Services offerings fastest path to revenue Active migration opportunities with New migration services pipeline PACS OEMs representing >60% of opportunities
Slide 29: Summary & Outlook
Summary & Outlook For personal use only Financials Outlook Our strategic acquisition of Laitek has propelled our commercial progress • Recognized Revenue in CY2025 anticipated to be in the order of US$9-11m (~A$14.5- 17.5m). Our recently announced collaboration with GE HealthCare is evidence of our
Slide 30: Questions
For personal use only Questions 28